Skip to main content
. Author manuscript; available in PMC: 2023 Jul 27.
Published in final edited form as: NeuroImmune Pharm Ther. 2022 Aug 15;2(2):95–101. doi: 10.1515/nipt-2022-0010

Figure 2. Assessment Scores in Relation to Age and Time Since Diagnosis.

Figure 2.

A linear regression model used time since diagnosis to predict scores. The dark blue line in panels C-F indicates the average control T score for that assessment.